» Articles » PMID: 39080603

Nephrectomy and High-salt Diet Inducing Pulmonary Hypertension and Kidney Damage by Increasing Ang II Concentration in Rats

Abstract

Background: Chronic kidney disease (CKD) is a significant risk factor for pulmonary hypertension (PH), a complication that adversely affects patient prognosis. However, the mechanisms underlying this association remain poorly understood. A major obstacle to progress in this field is the lack of a reliable animal model replicating CKD-PH.

Methods: This study aimed to establish a stable rat model of CKD-PH. We employed a combined approach, inducing CKD through a 5/6 nephrectomy and concurrently exposing the rats to a high-salt diet. The model's hemodynamics were evaluated dynamically, alongside a comprehensive assessment of pathological changes in multiple organs. Lung tissues and serum samples were collected from the CKD-PH rats to analyze the expression of angiotensin-converting enzyme 2 (ACE2), evaluate the activity of key vascular components within the renin-angiotensin-aldosterone system (RAAS), and characterize alterations in the serum metabolic profile.

Results: At 14 weeks post-surgery, the CKD-PH rats displayed significant changes in hemodynamic parameters indicative of pulmonary arterial hypertension. Additionally, right ventricular hypertrophy was observed. Notably, no evidence of pulmonary vascular remodeling was found. Further analysis revealed RAAS dysregulation and downregulated ACE2 expression within the pulmonary vascular endothelium of CKD-PH rats. Moreover, the serum metabolic profile of these animals differed markedly from the sham surgery group.

Conclusions: Our findings suggest that the development of pulmonary arterial hypertension in CKD-PH rats is likely a consequence of a combined effect: RAAS dysregulation, decreased ACE2 expression in pulmonary vascular endothelial cells, and metabolic disturbances.

References
1.
Ferreira A, Shenoy V, Yamazato Y, Sriramula S, Francis J, Yuan L . Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med. 2009; 179(11):1048-54. PMC: 2689912. DOI: 10.1164/rccm.200811-1678OC. View

2.
Iturriaga R, Castillo-Galan S . Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia. Curr Hypertens Rep. 2019; 21(11):89. DOI: 10.1007/s11906-019-0995-y. View

3.
Bush K, Singh P, Nigam S . Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease. JCI Insight. 2020; 5(7). PMC: 7205256. DOI: 10.1172/jci.insight.133817. View

4.
Karpinska O, Baranowska-Kuczko M, Kloza M, Ambroz Ewicz E, Kozlowski T, Kasacka I . Activation of CB receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. Am J Physiol Regul Integr Comp Physiol. 2017; 312(6):R883-R893. DOI: 10.1152/ajpregu.00324.2016. View

5.
Diwan V, Brown L, Gobe G . Adenine-induced chronic kidney disease in rats. Nephrology (Carlton). 2017; 23(1):5-11. DOI: 10.1111/nep.13180. View